KCA

This is an excerpt of an article from the 2024 IKCS: North America PROCEEDINGS, a publication of the Kidney Cancer Journal, which highlighted key research discussed at the Kidney Cancer Association's 2024 International Kidney Cancer Symposium (IKCS): North America held in Louisville, Kentucky on November 7-9, 2024. That meeting marked the 25th anniversary of IKCS meetings hosted by the Kidney…

Nicole and Keith Scott Team – 2025 KCA Regional Challenge: Ohio Team Captain – Nicole Scott, wife and caregiver for her husband Keith Scott, who was diagnosed with papillary renal cell carcinoma in 2023. Location – Mary Virginia Crites Hannan Park in Circleville, Ohio Date – May 10, 2025 Attendees: 100 Fundraising Goal – $1,000 Amount Raised – $11,222 (donations still coming in!) Activity – 5K Walk/Run…

Team – 2025 KCA Regional Challenge: Austin Team Captain – Annamaria Scaccia, 2-time cancer survivor and Member, KCA’s Patient & Caregiver Advisory Council Location – Lake Pflugerville Park, Pflugerville, Texas Date – April 12, 2025 Attendees: 11 Fundraising Goal – $3,000 Amount Raised – $3,284 Activity – 81-minute walk around Lake Pflugerville Event Highlights – My favorite highlight was seeing everyone show up and stay fully engaged throughout…

In a new episode of the Cancer Interviews podcast, host and prostate cancer survivor Bruce Morton speaks with Kidney Cancer Association Ambassador Jeff Kallis about his journey with kidney cancer and how it led him to advocacy. https://www.youtube.com/watch?v=hdU8LFPJk8I Jeff was diagnosed with stage 3 clear cell renal cell carcinoma in 2023. Since then, he’s not only navigated treatment and recovery, but found…

The 2025 International Kidney Cancer Symposium: Europe, taking place in Amsterdam on May 1-3, will feature three special lectures recognizing outstanding leaders in kidney cancer. Dr. Michael Staehler Dr. Michael Staehler will receive the KCA's John Fitzpatrick Award recognizing excellence in urology care. Dr. Staehler is the founder and head of the Interdisciplinary Center for Renal Tumours at Ludwig-Maximilians University…

A significant amount of new, practice-changing information about kidney cancer has been published and presented over the last 18 months. It can be challenging for nurses, pharmacists, nurse practitioners, physician assistants, and other clinicians to keep up with every update. No worries: a few members of the Kidney Cancer Association’s Clinical Advisory Board (CAB) conducted reviews for you and provided…

The Congressionally Directed Medical Research Programs (CDMRP) was created by Congress in 1992 to fund high-impact medical research—especially in areas overlooked by traditional sources—through the Department of Defense. CDMRP began with breast cancer research and has since expanded to support many conditions affecting both Service Members and civilians. https://www.kidneycancer.org/protect-federal-kidney-cancer-research-funding/ The CDMRP’s unique strength lies in backing high-risk, high-reward science: early-stage, innovative ideas that…

Kidney Cancer Unfiltered season 3 was filled with raw emotions, compelling stories, and powerful insights by both experts and those impacted by kidney cancer. Hosted by Annamaria Scaccia, this season featured remarkable guests who shared their personal experiences, shedding light on topics often overlooked in cancer conversations. I have listened to quite a few of these podcasts and find them…

Dr. Toni Choueiri and Dr. Rizwan Romee received a KCA research award in 2021 for their project “Adoptive cytokine-induced memory-like natural killer cell therapy alone or in combination with avelumab for immunotherapy-refractory advanced renal cell carcinoma.” This technique could represent a new type of immunotherapy treatment Choueiri, Romee, and Dr. Vincent Xu, shared an update on their research, which has…

Update 3/27/25: Why We Must Restore Funding For the CDMRP Update 3/24/25: Kidney cancer will not receive any funding this year through the CDMRP. A recent STAT News article summarized the far-reaching impacts of the "devastating" 57% cuts to the CDMRP, which, instead of reducing some funding for the 35 disease research programs supported by the CDMRP, eliminated funding for…